Adapting Biotech Leadership Across Development and Therapies
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Adapting Biotech Leadership Across Development and Therapies
-
ナレーター：
-
著者：
概要
Biotech leaders are asked to do a lot; move fast, manage limited resources, and guide teams through very different stages of development. In this episode of The Emerging Biotech Leader, host Kim Kushner talks with Dr. Benit Maru, Senior Vice President at SSI Strategy, about what it really looks like to lead in that environment.
They cover:
- The contrasts between early and late development leadership, and why those transitions can feel like two different roles
- How scenario planning and structured conversations help teams prepare for uncertainty
- Why documents like the clinical development plan or target product profile should be seen as living tools, not paper exercises
- The similarities and differences in leading across modalities—devices, biologics, and advanced therapies like cell and gene
- The importance of team dynamics, culture, and knowing when to bring in outside expertise
This episode is full of practical takeaways for biotech leaders who want to keep their strategies sound, their teams aligned, and their programs moving forward under pressure.
まだレビューはありません